Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.

International Ophthalmology
Umut DağMehmet Fuat Alakuş

Abstract

To present 11 bodybuilding athletes who developed central serous chorioretinopathy (CSCR) following high-dose subcutaneous follistatin-344, a peptide-based performance and image enhancing drug, injections to increase muscle mass. This is a retrospective case series from one institution. Demographic and clinical data of 11 patients who were admitted to our clinic with decreased visual acuity after high-dose follistatin-344 injections and optical coherence tomography (OCT) findings consistent with CSCR were analyzed. All 11 patients were male, and the mean age was 36.8 ± 8.1 years. All patients had a history of injecting complete 1 mg vials of follistatin-344 subcutaneously in the abdomen. There was a history of a single previous high-dose follistatin-344 injection in eight patients and multiple previous injections in three patients. At the time of diagnosis, ten patients had unilateral CSCR findings and one had bilateral CSCR findings. In all eight patients with a history of only one injection, subretinal fluid completely disappeared after an average of 2.3 ± 0.7 months and symptoms regressed. Recurrent CSCR developed in three patients with a history of multiple follistatin-344 injections. Follistatin-344 injection can be consid...Continue Reading

References

Feb 1, 1990·Molecular Endocrinology·N BillestrupW Vale
Apr 1, 1974·Archives of Ophthalmology·M L KleinS Chandra
Oct 24, 1998·The International Journal of Biochemistry & Cell Biology·K Patel
Nov 4, 1998·Frontiers in Neuroendocrinology·D J Phillips, D M de Kretser
Sep 11, 1999·American Journal of Ophthalmology·M K TittlJ A Sorenson
Dec 28, 1999·The British Journal of Ophthalmology·E M RochaD A Sullivan
Feb 1, 2000·American Journal of Ophthalmology·T IidaS Kishi
Mar 17, 2004·Ophthalmology·Robert HaimoviciUNKNOWN Central Serous Chorioretinopathy Case-Control Study Group
Oct 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Alan L SchneyerPatrick M Sluss
Dec 21, 2006·The British Journal of Ophthalmology·M C GrieshaberJ Flammer
Jun 5, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Mitzy E Torres-SorianoHugo Quiroz-Mercado
Feb 12, 2009·Muscle & Nerve·Louise R Rodino-KlapacJerry R Mendell
Jul 14, 2012·Clinical & Experimental Ophthalmology·Gerald LiewSamantha Fraser-Bell
Dec 22, 2012·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Moosang KimSeung-Jun Lee
May 21, 2014·Ophthalmic Surgery, Lasers & Imaging Retina·Sophia S WongLindsay M Smithen
Jun 1, 2015·Progress in Retinal and Eye Research·Alejandra DaruichFrancine Behar-Cohen
Jun 26, 2015·Retina·Jay ChhablaniUNKNOWN King Khaled Eye Specialist Hospital International Collaborative Retina Study Group
Mar 5, 2016·Retinal Cases & Brief Reports·Mandi D ConwayGholam A Peyman
Apr 7, 2016·BMJ : British Medical Journal·Jim McVeighFortune Ncube
Mar 18, 2017·Current Eye Research·Irini ChatziralliPanagiotis Mitropoulos
Jul 5, 2017·Survey of Ophthalmology·Benjamin P NicholsonSophie J Bakri
Aug 16, 2017·Journal of Proteome Research·Caroline BarbéJean-Paul Thissen
Apr 20, 2018·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Emine ÇiloğluNese Cetin Dogan
Jul 19, 2019·Progress in Retinal and Eye Research·Thomas J van RijssenCamiel J F Boon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.